Filing Details

Accession Number:
0001209191-20-057828
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 08:18:00
Reporting Period:
2020-11-10
Accepted Time:
2020-11-12 08:18:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197036 I Bruce Sachs C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 6,825 $216.47 18,035 No 4 P Direct
Common Stock Acquisiton 2020-11-10 4,270 $217.49 22,305 No 4 P Direct
Common Stock Acquisiton 2020-11-10 3,905 $218.79 26,210 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. Open market purchases reported on this line occurred at a weighted average price of $216.47 (range $216.01 to $217.00).
  2. Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
  3. Open market purchases reported on this line occurred at a weighted average price of $217.49 (range $217.05 to $218.04).
  4. Open market purchases reported on this line occurred at a weighted average price of $218.79 (range $218.21 to $219.00).